glp-1 afib HRS 2026: Receptor Agonists Reduce Atrial Fibrillation Risk Independently of Weight Loss GLP-1 Weight Loss & AFib

When GLP-1 binds to these receptors, it can shift macrophages from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype, inhibit the production of pro-inflammatory cytokines like TNF-, IL-1, and IL-6, increase anti-inflammatory adiponectin, and inhibit NF-B, a key regulator of pro-inflammatory gene expression

Check with your insurance provider to see if any aspects of the treatment may be covered

Methods 4 , 100710 (2024)

If you are still early in the process, complete the free assessment quiz to see whether a personalized program makes sense for you

In this episode of the Building Lifelong Athletes podcast, we dive into the research on BPC-157 and explore the potential risks and benefits of this peptide